Rare diseases
Investigational molecules
Locations
Back to Germany111 clinical trials in Bad Bentheim, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata
GermanyStudy on the Effectiveness and Safety of Litifilimab for Patients with Active Subacute or Chronic Cutaneous Lupus Erythematosus Resistant to Antimalarial Therapy
GermanyStudy on the Safety and Effectiveness of Ritlecitinib in Adults and Adolescents with Nonsegmental Vitiligo
GermanyStudy on Long-Term Use of Spesolimab for Patients with Hidradenitis Suppurativa Who Completed a Previous Spesolimab Study
GermanyStudy on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More
GermanyStudy on the Effectiveness and Safety of Amlitelimab for Patients Aged 12 and Older with Moderate-to-Severe Atopic Dermatitis Using Topical Corticosteroids
GermanyLong-Term Study of Ritlecitinib Tosilate for Adults and Adolescents with Alopecia Areata
GermanyStudy Comparing Risankizumab and Deucravacitinib for Adults with Moderate Plaque Psoriasis Eligible for Systemic Therapy
GermanyStudy on the Safety of Tirbanibulin and Diclofenac Sodium for Adults with Actinic Keratosis on the Face or Scalp
GermanyStudy on Bimekizumab and Ustekinumab for Children and Teens with Moderate to Severe Plaque Psoriasis
GermanyStudy on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of Ruxolitinib Cream for Adults with Chronic Hand Eczema
GermanyThe busiest research cities in the country
What the registry says about research in the country
Several groundbreaking trials focusing on plaque psoriasis and psoriatic arthritis are evaluating novel therapeutic approaches. Research includes comparative studies of new biological treatments and long-term safety assessments.
These studies aim to improve treatment outcomes for patients with varying severities of psoriatic conditions.
Innovative clinical trials are investigating treatments for atopic dermatitis and chronic hand eczema. Studies range from evaluating new biological therapies to investigating dose optimization strategies.
Research focuses on both adult and adolescent populations, with emphasis on long-term efficacy and safety.
Research initiatives addressing various dermatological conditions, including hidradenitis suppurativa, prurigo nodularis, and actinic keratosis. Novel therapeutic approaches are being tested.
These trials aim to develop targeted treatments for challenging skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
